Recent studies suggest a strong positive correlation between testosterone levels and sperm parameters in diabetic patients, highlighting the impact of testosterone deficiency on spermatogenesis [264]
The US Food and Drug Administration (FDA) initally approved semaglutide 2.4 mg in June 2021, for chronic weight management in adults with obesity or overweight, marking a landmark approval for the glucagon-like peptide-1 receptor agonist (GLP-1 RA) class
Presynaptic spike timing-dependent long-term depression in the mouse hippocampus
To view a copy of this licence, visit About this article Cite this article Singh, R., Shah, A., Jain, N
Additionally, some patients may benefit from dose optimisation gradually increasing to the maximum tolerated or licensed doseas higher doses generally produce greater weight loss and metabolic improvements
Int J Obes 49 , 402411 (2025)